Director, Prostate Diagnostic Laboratory
Co-Director, Prostate Cancer Research Laboratories
Co-Director, Colorado Molecular Correlates Laboratory (CMOCO)
Phone: (303) 724-3470
Fax: (303) 724-0709
M. Scott Lucia, M.D. is Associate Professor and Chief of Genitourinary and Renal Pathology at the University of Colorado Denver (UCD) School of Medicine where he also serves as the Director of the Prostate Diagnostic Laboratory, Prostate Cancer Research Laboratories, and UCD Biorepository Core Facility. Dr. Lucia received his M.D. from the University of Colorado School of Medicine in 1988. He completed his internship and residency in pathology at the University of Colorado in 1993. He was a research fellow in the Laboratory of Chemoprevention at the National Institutes of Health from 1993-1995 before returning to Colorado in 1995.
Dr. Lucia served as the primary pathologist for the Prostate Cancer Prevention Trial (PCPT) and Vitamin E and Selenium Chemoprevention Trial (SELECT), sponsored by the Southwest Oncology Group, and the Medical Therapy of Prostate Symptoms (MTOPS) trial, sponsored by the NIDDK. He currently is the primary pathologist for the Reduction with Dutasteride of Clinical Progression Events in Expectant Management of Prostate Cancer (REDEEM) sponsored by GlaxoSmithKline. He directs the operation of several tissue and serum biorepositories for prostate and prostatic diseases including those for the PCPT, MTOPS, SELECT, and the University of Colorado Cancer Center Prostate Biorepository. He has authored or co-authored over 90 peer-reviewed articles, reviews and book chapters. His primary areas of interest include pathology of prostate cancer and hyperplasia, early detection and prevention of prostate cancer, and mechanisms of carcinogenesis.